Reviewed,
UniProtKB/Swiss-Prot Q07820 (MCL1_HUMAN)
Last modified
February 9, 2010.
Version 107.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Induced myeloid leukemia cell differentiation protein Mcl-1 Alternative name(s): Bcl-2-related protein EAT/mcl1 mcl1/EAT Bcl-2-like protein 3 Short name=Bcl2-L-3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 350 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Involved in the regulation of apoptosis versus cell survival, and in the maintenance of viability but not of proliferation. Mediates its effects by interactions with a number of other regulators of apoptosis. Isoform 1 inhibits apoptosis. Isoform 2 promotes apoptosis. Ref.4 |
| Subunit structure | Interacts with BAD, BOK, BIK and BFM By similarity. Interacts with PMAIP1. Isoform 1 interacts with BAX, BAK1, TPT1 and BCL2L11. Heterodimer of isoform 1 and isoform 2. Homodimers of isoform 1 or isoform 2 are not detected. Isoform 2 does not interact with pro-apoptototic BCL2-related proteins. Ref.5 Ref.14 Ref.16 |
| Subcellular location | Membrane; Single-pass membrane protein Potential. Cytoplasm. Mitochondrion. Nucleus › nucleoplasm. Note: Cytoplasmic, associated with mitochondria. Ref.14 Ref.16 |
| Induction | Expression increases early during phorbol-ester induced differentiation along the monocyte/macrophage pathway in myeloid leukemia cell lines ML-1. Rapidly up-regulated by CSF2 in ML-1 cells. Up-regulated by heat-shock induced differentiation. Expression increases early during retinoic acid-induced differentiation. Ref.2 Ref.13 |
| Post-translational modification | Cleaved by CASP3 during apoptosis. In intact cells cleavage occurs preferentially after Asp-127, yielding a pro-apoptotic 28 kDa C-terminal fragment. Rapidly degraded in the absence of phosphorylation on Thr-163 in the PEST region. Phosphorylated on Thr-163. Treatment with taxol or okadaic acid induces phosphorylation on additional sites. Ref.15 Ref.17 Ref.19 |
| Sequence similarities | Belongs to the Bcl-2 family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| BAK1 | Q16611 | 3 | EBI-1003422,EBI-519866 | |
| BBC3 | Q9BXH1 | 1 | EBI-1003422,EBI-519884 | |
| BCL2L11 | O43521 | 1 | EBI-1003422,EBI-526406 | |
| BID | P55957 | 1 | EBI-1003422,EBI-519672 | |
| BIK | Q13323 | 1 | EBI-1003422,EBI-700794 | |
| Bmf | Q91ZE9 | 1 | EBI-1003422,EBI-708032 | From a different organism. |
| PMAIP1 | Q13794 | 1 | EBI-1003422,EBI-707392 | |
| Pmaip1 | Q9JM54 | 1 | EBI-1003422,EBI-709183 | From a different organism. |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q07820-1) Also known as: MCL1L; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q07820-2) Also known as: Delta S; MCL-1S; TM; The sequence of this isoform differs from the canonical sequence as follows: 231-271: MLRKLDIKNE...GRIVTLISFG → WVCGVLPCRG...FGISNKIALL 272-350: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 350 | 350 | Induced myeloid leukemia cell differentiation protein Mcl-1 | PRO_0000143080 | ||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||
| Transmembrane | 328 – 348 | 21 | Potential | |||||||||||||||||||||||
| Region | 104 – 175 | 72 | PEST-like | |||||||||||||||||||||||
| Motif | 209 – 223 | 15 | BH3 | |||||||||||||||||||||||
| Motif | 252 – 272 | 21 | BH1 | |||||||||||||||||||||||
| Motif | 304 – 319 | 16 | BH2 | |||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||
| Site | 127 – 128 | 2 | Cleavage; by caspase-3 | |||||||||||||||||||||||
| Site | 157 – 158 | 2 | Cleavage; by caspase-3 | |||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||
| Modified residue | 121 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||
| Modified residue | 163 | 1 | Phosphothreonine; by MAPK Ref.15 Ref.17 Ref.19 | |||||||||||||||||||||||
| Cross-link | 5 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
| Cross-link | 40 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
| Cross-link | 136 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
| Cross-link | 194 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
| Cross-link | 197 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||
| Alternative sequence | 231 – 271 | 41 | MLRKL…LISFG → WVCGVLPCRGPRRWHQECAA GFCRCCWSRSWFGISNKIAL L in isoform 2. | VSP_000532 | ||||||||||||||||||||||
| Alternative sequence | 272 – 350 | 79 | Missing in isoform 2. | VSP_000533 | ||||||||||||||||||||||
| Natural variant | 173 | 1 | E → D: dbSNP rs2737820. Ref.4 Ref.1 | VAR_024021 | ||||||||||||||||||||||
| Natural variant | 227 | 1 | A → V: dbSNP rs11580946. Ref.7 Ref.8 Ref.11 | VAR_024022 | ||||||||||||||||||||||
| Natural variant | 231 | 1 | M → L | VAR_054157 | ||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||
| Mutagenesis | 5 | 1 | K → R: Reduced ubiquitination. Ref.18 | |||||||||||||||||||||||
| Mutagenesis | 40 | 1 | K → R: Reduced ubiquitination. Ref.18 | |||||||||||||||||||||||
| Mutagenesis | 127 | 1 | D → A: Abolishes formation of 28 and 17 kDa cleavage products by CASP3. Abolishes cleavage by caspase-3; when associated with A-157. Ref.12 | |||||||||||||||||||||||
| Mutagenesis | 136 | 1 | K → R: Reduced ubiquitination. Ref.18 | |||||||||||||||||||||||
| Mutagenesis | 157 | 1 | D → A: Abolishes formation of 23 and 21 kDa cleavage products by CASP3. Abolishes cleavage by caspase-3; when associated with A-127. Ref.12 | |||||||||||||||||||||||
| Mutagenesis | 162 | 1 | S → A: No effect. Ref.17 | |||||||||||||||||||||||
| Mutagenesis | 163 | 1 | T → A: Abolishes phosphorylation by MAPK. No effect on phosphorylation induced by okadaic acid or taxol. Ref.17 | |||||||||||||||||||||||
| Mutagenesis | 194 | 1 | K → R: Reduced ubiquitination. Ref.18 | |||||||||||||||||||||||
| Mutagenesis | 197 | 1 | K → R: Reduced ubiquitination. Ref.18 | |||||||||||||||||||||||
| Mutagenesis | 208 | 1 | K → R: No effect on ubiquitination. Ref.18 | |||||||||||||||||||||||
| Mutagenesis | 234 | 1 | K → R: No effect on ubiquitination. Ref.18 | |||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||
| Helix | 173 – 191 | 19 | ||||||||||||||||||||||||
| Helix | 204 – 221 | 18 | ||||||||||||||||||||||||
| Helix | 225 – 235 | 11 | ||||||||||||||||||||||||
| Helix | 244 – 253 | 10 | ||||||||||||||||||||||||
| Helix | 254 – 256 | 3 | ||||||||||||||||||||||||
| Helix | 261 – 281 | 21 | ||||||||||||||||||||||||
| Helix | 288 – 301 | 14 | ||||||||||||||||||||||||
| Helix | 303 – 308 | 6 | ||||||||||||||||||||||||
| Turn | 309 – 311 | 3 | ||||||||||||||||||||||||
| Helix | 312 – 318 | 7 | ||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2." Kozopas K.M., Yang T., Buchan H.L., Zhou P., Craig R.W. Proc. Natl. Acad. Sci. U.S.A. 90:3516-3520(1993) [PubMed: 7682708] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ASP-173. Tissue: Myeloid leukemia cell. |
| [2] | "Induction of mcl1/EAT, Bcl-2 related gene, by retinoic acid or heat shock in the human embryonal carcinoma cells, NCR-G3." Umezawa A., Maruyama T., Inazawa J., Imai S., Takano T., Hata J. Cell Struct. Funct. 21:143-150(1996) [PubMed: 8790944] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION. |
| [3] | "Functional analysis of the human MCL-1 gene." Akgul C., Turner P.C., White M.R.H., Edwards S.W. Cell. Mol. Life Sci. 57:684-691(2000) [PubMed: 11130466] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | "Exon skipping in Mcl-1 results in a Bcl-2 homology domain 3 only gene product that promotes cell death." Bingle C.D., Craig R.W., Swales B.M., Singleton V., Zhou P., Whyte M.K.B. J. Biol. Chem. 275:22136-22146(2000) [PubMed: 10766760] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), VARIANT ASP-173, FUNCTION. Tissue: Myeloid leukemia cell and Neuroblastoma. |
| [5] | "MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain." Bae J., Leo C.P., Hsu S.Y., Hsueh A.J.W. J. Biol. Chem. 275:25255-25261(2000) [PubMed: 10837489] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), INTERACTION WITH BAX; BAK1; BCL2L11 AND BETWEEN ISOFORMS 1 AND 2. |
| [6] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [7] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT VAL-227. Tissue: Thalamus. |
| [8] | NIEHS SNPs program Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT VAL-227. |
| [9] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [10] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Mammary gland and Placenta. |
| [11] | "Acute myeloid leukemia possessing jumping translocation is related to highly elevated levels of EAT/mcl-1, a Bcl-2 related gene with anti-apoptotic functions." Okita H., Umezawa A., Fukuma M., Hata J. Leuk. Res. 24:73-77(2000) [PubMed: 10634649] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 182-289 (ISOFORM 1), VARIANT VAL-227. Tissue: Ewing sarcoma. |
| [12] | "Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage." Michels J., O'Neill J.W., Dallman C.L., Mouzakiti A., Habens F., Brimmell M., Zhang K.Y.J., Craig R.W., Marcusson E.G., Johnson P.W.M., Packham G. Oncogene 23:4818-4827(2004) [PubMed: 15122313] [Abstract] Cited for: PROTEIN SEQUENCE OF N-TERMINUS OF FRAGMENTS OBTAINED BY CASPASE CLEAVAGE, MUTAGENESIS OF ASP-127 AND ASP-157. |
| [13] | "Mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response." Chao J.-R., Wang J.-M., Lee S.-F., Peng H.-W., Lin Y.-H., Chou C.-H., Li J.-C., Huang H.-M., Chou C.-K., Kuo M.-L., Yen J.J.-Y., Yang-Yen H.-F. Mol. Cell. Biol. 18:4883-4898(1998) [PubMed: 9671497] [Abstract] Cited for: INDUCTION. |
| [14] | "Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and fortilin. The potential role of MCL1 as a fortilin chaperone." Zhang D., Li F., Weidner D., Mnjoyan Z.H., Fujise K. J. Biol. Chem. 277:37430-37438(2002) [PubMed: 12149273] [Abstract] Cited for: INTERACTION WITH TPT1, SUBCELLULAR LOCATION. |
| [15] | "Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress." Inoshita S., Takeda K., Hatai T., Terada Y., Sano M., Hata J., Umezawa A., Ichijo H. J. Biol. Chem. 277:43730-43734(2002) [PubMed: 12223490] [Abstract] Cited for: PHOSPHORYLATION AT SER-121 AND THR-163. |
| [16] | "Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex." Leu J.I.-J., Dumont P., Hafey M., Murphy M.E., George D.L. Nat. Cell Biol. 6:443-450(2004) [PubMed: 15077116] [Abstract] Cited for: INTERACTION WITH BAK, SUBCELLULAR LOCATION. |
| [17] | "MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol." Domina A.M., Vrana J.A., Gregory M.A., Hann S.R., Craig R.W. Oncogene 23:5301-5315(2004) [PubMed: 15241487] [Abstract] Cited for: PHOSPHORYLATION AT THR-163, MUTAGENESIS OF SER-162 AND THR-163. |
| [18] | "Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis." Zhong Q., Gao W., Du F., Wang X. Cell 121:1085-1095(2005) [PubMed: 15989957] [Abstract] Cited for: UBIQUITINATION, MUTAGENESIS OF LYS-5; LYS-40; LYS-136; LYS-194; LYS-197; LYS-208 AND LYS-234. |
| [19] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-163, MASS SPECTROMETRY. |
| [20] | "Structural insights into the degradation of Mcl-1 induced by BH3 domains." Czabotar P.E., Lee E.F., van Delft M.F., Day C.L., Smith B.J., Huang D.C.S., Fairlie W.D., Hinds M.G., Colman P.M. Proc. Natl. Acad. Sci. U.S.A. 104:6217-6222(2007) [PubMed: 17389404] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 151-307 IN COMPLEXES WITH PMAIP1 AND BCL2L11. |
| [21] | "X-ray crystal structure of human MCL-1 in complex with BIM BH3." Bare E., Grant R.A., Keating A.E. Submitted (JUN-2007) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 172-327 IN COMPLEX WITH BCL2L11. |
| [22] | "DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome." Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K., Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L., Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A., Abbott S. Wilson R.K.Nature 456:66-72(2008) [PubMed: 18987736] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] LEU-231. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | L08246 mRNA. No translation available. AF118124 mRNA. Translation: AAD13299.1. AF147742 Genomic DNA. Translation: AAF74821.1. AF198614 Genomic DNA. Translation: AAF64255.1. AF198614 Genomic DNA. Translation: AAF64256.1. AF162677, AF162676 Genomic DNA. Translation: AAG00896.1. AF203373 mRNA. Translation: AAG00904.1. BT006640 mRNA. Translation: AAP35286.1. AK312508 mRNA. Translation: BAG35409.1. DQ088966 Genomic DNA. Translation: AAY68220.1. AL356356 Genomic DNA. Translation: CAI15503.1. AL356356 Genomic DNA. Translation: CAI15504.1. BC017197 mRNA. Translation: AAH17197.1. BC071897 mRNA. Translation: AAH71897.1. BC107735 mRNA. Translation: AAI07736.1. AF118276 mRNA. Translation: AAF15309.1. AF118277 mRNA. Translation: AAF15310.1. AF118278 mRNA. Translation: AAF15311.1. | ||||||||||||||||||||||||||||||||||||||||||
| IPI | IPI00030356. IPI00221306. | ||||||||||||||||||||||||||||||||||||||||||
| PIR | A47476. | ||||||||||||||||||||||||||||||||||||||||||
| RefSeq | NP_068779.1. NP_877495.1. | ||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||||||||
| DIP | DIP-231N. | ||||||||||||||||||||||||||||||||||||||||||
| IntAct | Q07820. 9 interactions. | ||||||||||||||||||||||||||||||||||||||||||
| STRING | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||||||||
| PhosphoSite | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||||||||
| PRIDE | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000369026; ENSP00000358022; ENSG00000143384; Homo sapiens. [Genome view] | ||||||||||||||||||||||||||||||||||||||||||
| GeneID | 4170. | ||||||||||||||||||||||||||||||||||||||||||
| KEGG | hsa:4170. | ||||||||||||||||||||||||||||||||||||||||||
| UCSC | uc001euz.1. human. uc001eva.1. human. | ||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||
| CTD | 4170. | ||||||||||||||||||||||||||||||||||||||||||
| GeneCards | GC01M148813. | ||||||||||||||||||||||||||||||||||||||||||
| H-InvDB | HIX0001031. | ||||||||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:6943. MCL1. | ||||||||||||||||||||||||||||||||||||||||||
| HPA | CAB002781. HPA008455. | ||||||||||||||||||||||||||||||||||||||||||
| MIM | 159552. gene. | ||||||||||||||||||||||||||||||||||||||||||
| PharmGKB | PA30688. | ||||||||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||
| eggNOG | prNOG17289. | ||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
| InParanoid | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
| OMA | KDTKPMG. | ||||||||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG9WDGX1. | ||||||||||||||||||||||||||||||||||||||||||
| PhylomeDB | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | hif1_tfpathway. HIF-1-alpha transcription factor network. il6_7pathway. IL6-mediated signaling events. | ||||||||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||||||||
| ArrayExpress | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
| Bgee | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
| CleanEx | HS_MCL1. | ||||||||||||||||||||||||||||||||||||||||||
| Genevestigator | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000143384. Homo sapiens. | ||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR013281. Apop_reg_Mc1. IPR002475. BCL2_apoptsis. IPR000712. Bcl2_BH. IPR020717. Bcl2_BH1_motif_CS. IPR020726. Bcl2_BH2_motif_CS. IPR020728. Bcl2_BH3_motif_CS. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF00452. Bcl-2. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| PRINTS | PR01866. APOPREGMCL1. PR01862. BCL2FAMILY. | ||||||||||||||||||||||||||||||||||||||||||
| SMART | SM00337. BCL. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| PROSITE | PS50062. BCL2_FAMILY. 1 hit. PS01080. BH1. 1 hit. PS01258. BH2. 1 hit. PS01259. BH3. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||||||||||||||
| NextBio | 16422. | ||||||||||||||||||||||||||||||||||||||||||
| PMAP-CutDB | Q07820. | ||||||||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | MCL1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q07820 Secondary accession number(s): B2R6B2 Q9UNJ1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |
| Forthcoming format changes Announcement of forthcoming format changes |

Clusters with


